“Hills and Valleys of Biotech investing – A Historical Perspective”
When: November 20, 2001
(of Alta Partners)
Farah Champsi joined Alta Partners in May 2000. Prior to that, Ms. Champsi was an investment banker for more than 16 years. Between May 1987 and December 1999, Ms. Champsi was an investment banker at Robertson, Stephens & Company, most recently as co-head of the Global Life Sciences Investment Banking Group. Her responsibilities included raising public and private capital and providing advisory services to leading emerging growth biotechnology, pharmaceutical and medical technology companies. She was responsible for identifying, developing and managing client relationships with leading biopharmaceutical companies such as Chiron, Gilead, Millennium, Affymetrix and Abgenix. She was elected a general partner of Robertson Stephens in 1992 and head of life sciences investment banking in 1995. She helped raise over $3 billion of capital in more than 50 transactions since 1995.
She is a board member of the Stanford Business School Trust, the Advisory Council of the UC Berkeley School of Public Health, Cytokinetics, a private biopharmaceutical company, Myocor, Inc., a private clinical stage medical device company, and Renovis, a private neuroscience company. She received an M.B.A. from Stanford University and a B.A. from Smith College.